These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Narita I, Border WA, Ketteler M, Noble NA. Lab Invest; 1995 Jan; 72(1):17-24. PubMed ID: 7837786 [Abstract] [Full Text] [Related]
25. The effects of nitric oxide synthase blockers on mesenteric blood flow with bile duct ligation. Yuksel BC, Tanriverdi P, Ozel H, Avsar FM, Topaloglu S, Iskit AB. Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxix-ccxxi. PubMed ID: 15244184 [Abstract] [Full Text] [Related]
26. Inhibition of capillary growth in chronically stimulated rat muscles by N(G)-nitro-l-arginine, nitric oxide synthase inhibitor. Hudlická O, Brown MD, Silgram H. Microvasc Res; 2000 Jan; 59(1):45-51. PubMed ID: 10625570 [Abstract] [Full Text] [Related]
27. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels. Bugajski J, Gadek-Michalska A, Głód R, Borycz J. J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702 [Abstract] [Full Text] [Related]
29. Salt and nitric oxide inhibition induced hypertension: the role of prostacycline and 8-isoprostane. Ilhan S, Oktar S, Sahna E, Aksulu HE. Clin Exp Hypertens; 2011 Dec; 33(2):84-8. PubMed ID: 21214402 [Abstract] [Full Text] [Related]
30. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations. Verhagen AM, Braam B, Boer P, Gröne HJ, Koomans HA, Joles JA. Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696 [Abstract] [Full Text] [Related]
31. Capillary reperfusion after L-arginine, L-NMMA, and L-NNA treatment in cheek pouch microvasculature. Bertuglia S, Colantuoni A, Intaglietta M. Microvasc Res; 1995 Sep; 50(2):162-74. PubMed ID: 8538497 [Abstract] [Full Text] [Related]
33. Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat. Cattell V, Smith J, Jansen A, Riveros-Moreno V, Moncada S. Transplantation; 1994 Dec 27; 58(12):1399-402. PubMed ID: 7528951 [Abstract] [Full Text] [Related]
34. Chronic renal allograft rejection. Selective involvement of the glomerular endothelium in humoral immune reactivity and intravascular coagulation. Duijvestijn AM, van Breda Vriesman PJ. Transplantation; 1991 Aug 27; 52(2):195-202. PubMed ID: 1871789 [Abstract] [Full Text] [Related]
37. Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy. Neto JS, Nakao A, Toyokawa H, Nalesnik MA, Romanosky AJ, Kimizuka K, Kaizu T, Hashimoto N, Azhipa O, Stolz DB, Choi AM, Murase N. Am J Physiol Renal Physiol; 2006 Feb 27; 290(2):F324-34. PubMed ID: 16131650 [Abstract] [Full Text] [Related]
38. Chronic inhibition of nitric oxide synthase activity by NG-nitro-L-arginine induces nitric oxide synthase expression in the developing rat cerebellum. Serfőző Z, Lontay B, Kukor Z, Erdődi F. Neurochem Int; 2012 May 27; 60(6):605-15. PubMed ID: 22391324 [Abstract] [Full Text] [Related]
39. Effects of L-NMMA and L-NNA on the selective ATP-induced enhancement of intratumoral blood flow. Natori Y, Moriguchi M, Fujiwara S, Takeshita I, Fukui M, Iwaki T, Kanaide H. J Cereb Blood Flow Metab; 1992 Jan 27; 12(1):120-7. PubMed ID: 1727133 [Abstract] [Full Text] [Related]
40. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. Gröne HJ, Weber C, Weber KS, Gröne EF, Rabelink T, Klier CM, Wells TN, Proudfood AE, Schlöndorff D, Nelson PJ. FASEB J; 1999 Aug 27; 13(11):1371-83. PubMed ID: 10428761 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]